Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 3,971 | 3,056 | 23,015 | 3,014 | 3,015 |
| Gross Profit | 3,971 | 3,056 | 23,015 | 3,014 | 3,015 |
| Operating Expenses | 32,237 | 32,831 | 30,329 | 31,430 | 28,905 |
| Operating Income | -28,266 | -29,775 | -7,314 | -28,416 | -25,890 |
| Interest Expense | 0 | 0 | 0 | 0 | -416 |
| Other Income | 347 | 822 | 379 | 398 | 0 |
| Pre-tax Income | -27,919 | -28,953 | -6,935 | -28,018 | -25,474 |
| Net Income Continuous | -27,919 | -28,953 | -6,935 | -28,018 | -25,474 |
| Net Income | $-27,919 | $-28,953 | $-6,935 | $-28,018 | $-25,474 |
| EPS Basic Total Ops | -13.80 | -14.40 | -3.40 | -13.80 | -12.60 |
| EPS Basic Continuous Ops | -13.74 | -14.28 | -3.43 | -13.87 | -12.62 |
| EPS Diluted Total Ops | -13.80 | -14.40 | -3.40 | -13.80 | -12.60 |
| EPS Diluted Continuous Ops | -13.74 | -14.28 | -3.43 | -13.87 | -12.62 |
| EBITDA(a) | $-26,375 | $-27,922 | $-5,498 | $-26,713 | $-24,219 |